Canadian Association of Gastroenterology position statement regarding the use of thiopurines for the treatment of inflammatory bowel disease

MeSH terms

• Azathioprine / adverse effects*
• Canada
• Gastroenterology
• Humans
• Immunosuppressive Agents / adverse effects*
• Inflammatory Bowel Diseases / drug therapy*
• Inflammatory Bowel Diseases / pathology
• Liver Neoplasms / chemically induced
• Liver Neoplasms / prevention & control
• Lymphoma, T-Cell / chemically induced
• Lymphoma, T-Cell / prevention & control
• Mercaptopurine / adverse effects*
• Societies, Medical
• Splenic Neoplasms / chemically induced
• Splenic Neoplasms / prevention & control